...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review
【24h】

Efficacy and safety of olanzapine for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) as reported in phase I and II studies: a systematic review

机译:一期和二期研究报告的奥氮平预防化疗引起的恶心和呕吐(CINV)的功效和安全性:系统综述

获取原文
获取原文并翻译 | 示例
           

摘要

Olanzapine is an atypical antipsychotic drug that inhibits serotonergic, dopaminergic, alpha-1 adrenergic, histaminic, and muscarinic receptors. Several phase I and II trials have been published documenting the use of olanzapine in controlling chemotherapy-induced nausea and vomiting (CINV). This review aims to summarize all phase I and II trials that reported on olanzapine for the prophylaxis of CINV.
机译:奥氮平是一种非典型的抗精神病药,可抑制血清素,多巴胺,α-1肾上腺素,组织蛋白和毒蕈碱受体。已经发表了一些I和II期试验,记录了奥氮平在控制化疗引起的恶心和呕吐(CINV)中的用途。本文旨在总结奥氮平预防CINV的所有I期和II期试验。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号